Search

Tian QX, Zhang ZH, Ye QL, et al. J Inflamm Res. 2021;14:2253–2265. We, the Editors and Publisher of Journal of Inflammation Research, have retracted the following article. Following publication of the article, the authors raised concerns regarding the duplication of images from Figure 1. Specifically, The images for Figure 1A, PC-3, MT, 12h and 24h have been duplicated. The images for Figure 1B, DU145, MT and Figure 1C, PC-3, Control and MT+LPS have been duplicated. The images for Figure 1C, DU145, MT+LPS and PC-3, MT have been duplicated. The authors explained the incorrect use of images occurred during figure preparation and did provide some of the original data for the study. However, the provided data and the authors explanation regarding the duplicated images did not sufficiently alleviate the journal’s concerns regarding the validity of the findings. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article and the authors do not agree with this decision. We have been informed in our decision-making by our editorial policies and COPE guidelines. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.

Qi-Xing Tian,1,* Zhi-Hui Zhang,1,* Qing-Lin Ye,1 Shen Xu,1 Qian Hong,1 Wei-Yang Xing,1 Lei Chen,1 De-Xin Yu,1 De-Xiang Xu,2,3 Dong-Dong Xie1 1Department of Urology, Second Affiliated Hospital, Anhui Medical University, Hefei, 230601, People’s Republic of China; 2Department of Toxicology, Anhui Medical University, Hefei, 230032, People’s Republic of China; 3Laboratory of Environmental Toxicology, Anhui Medical University, Hefei, 230032, People’s Republic of China*These authors contributed equally to this workCorrespondence: De-Xiang XuDepartment of Toxicology, Anhui Medical University, Hefei, 230032, People’s Republic of ChinaTel +86 138 6674 1832Email xudex@126.comDong-Dong XieDepartment of Urology, Second Affiliated Hospital, Anhui Medical University, Hefei, 230601, People’s Republic of ChinaTel +86 138 6670 0010Email xiedd_urology@163.comPurpose: Gram-negative bacteria are usually found in prostate cancer (PCa) tissues. This study aims to investigate the role of lipopolysaccharide (LPS), a glycolipid compound found in the outer membrane of gram-negative bacteria, on the migration and invasion of PCa cells, and to evaluate the protective effect of melatonin.Materials and Methods: DU145, PC-3 and LNCaP cells were incubated with LPS in the presence or absence of melatonin. Wound healing and Transwell assays were used to analyze migration and invasion of PCa cells. RT-PCR and Western blotting were used to assess the mRNA and protein levels, respectively. Co-IP was used to analyze β-catenin ubiquitination.Results: Our results showed that LPS promoted migration and invasion of PCa cells. In addition, LPS stimulated inflammatory reaction and induced epithelial–mesenchymal transition (EMT) in PCa cells by activating several TLR4 downstream pathways. Specifically, LPS promoted NF-κB/IL-6/STAT3 signal transduction. In addition, LPS upregulated phosphorylation levels of cytoplasmic AKTSer473 and GSK-3βSer9. Moreover, LPS induced phosphorylation of GSK-3βSer9 in the “disruption complex”, and then inhibited phosphorylation and ubiquitination of cytoplasmic β-catenin, leading to β-catenin nuclear translocation. Interestingly, melatonin inhibited invasion and migration not only in LPS-stimulated but also in LPS-unstimulated PCa cells. Melatonin suppressed PCa cells migration and invasion by blocking EMT mediated by IL-6/STAT3, AKT/GSK-3β and β-catenin pathways.Conclusion: This study provides evidence that melatonin inhibits migration and invasion through blocking multiple TLR4 downstream EMT-associated pathways both in LPS-stimulated and -unstimulated PCa cells. Our results provide new insights into the role of bacterial infection in PCa metastasis and a potential therapeutic agent.Keywords: β-catenin, EMT, lipopolysaccharide, melatonin, prostate cancer